1. Phase II study of taxotere in ovarian cancer;Aapro;Ann Oncol,1994
2. Experimental antitumor activity of Taxotere (RP 56976, NSC 628503), a taxol analogue;Bissery;Cancer Res,1991
3. Preclinical profile of docetaxel (Taxotere), efficacy as a single agent and in combination;Bissery;Semin Oncol,1995
4. Phase I and pharmacokinetic study of taxotere administered as a 24 hour infusion;Bissett;Cancer Res,1993
5. Phase II study and long term follow up of patients treated with taxol for advanced ovarian adenocarcinoma;Einzig;J Clin Oncol,1992